Medical Genomics & Biomarkers

HSOA Journal of Medical Genomics & Biomarkers

Journal of Medical Genomics & Biomarkers is an multidisciplinary international peer reviewed open access journal, which provides a platform for researchers and practitioners everywhere throughout the world to promote, impart and inspect distinctive new issues and headways within the scope of the journal.

A biomarker is a biological molecule found in blood, body fluids, or tissues that may indicate an abnormal condition, or a disease. The level of a particular biomarker may indicate a patient's risk of disease, or likely response to the medication given. The journal covers all aspects of fundamental medicinal science and translational requisitions in the fields of biomarkers, cell signaling, genomic medicine, biotechnology, pharmacogenomics and health sciences.

The journal disseminates remarkable papers including but not limited to the following fields:

  • Neuroblastoma
  • Palliative care
  • Pediatric and other malignancies
  • Pediatric oncology
  • Psychosocial aspects of survivorship
  • Relapsed Cancer
  • Sarcomas
  • Acute lymphoblastic anemia
  • Acute lymphocytic leukemia
  • Anemias
  • Cancer genetics
  • Chemo-resistance
  • Childhood Lymphoma
  • Chromatin remodeling
  • Cytotoxic T-lymphocytes
  • Epigenetics in cancer
  • Gene Therapy
  • Genetics of immune function
  • Leukemia stem cell biology
  • Lymphoma
  • Nerve cell proliferation
  • Stem Cells
  • T cell development and function

Transplant immunology

A global representation on the publication board will help propel the practice globally and shed light on universal developments in practice, education and research, with a single common objective to study the significant role of biomarkers and genomic medicine in the advancement of personalized medicine and healthcare.